American Academy of Ophthalmology

Articles

Katherine Talcott, MD, of Cole Eye Institute, discusses results of a 5-year study examining endogenous bacterial endophthalmitis at a tertiary care center from AAO 2019. 

Katherine Talcott, MD: 5-Year Review of Endogenous Bacterial Endophthalmitis

Sumayya Ahmad, MD, assistant professor of medicine at Icahn School of Medicine at Mount Sinai, discusses results of a study she presented at AAO 2019 that examined the real-world survival rates of penetrating keratoplasty.

Real-World Survival Rates of Keratoplasty

Katherine Talcott, MD, of the Cole Eye Institute, discusses the results of a study she co-authored from AAO 2019 that examined visual acuity outcomes after cataract extraction with IOL implantation with diabetic eyes. 

Visual Outcomes After Cataract Surgery in Diabetic Eyes

Rishi Singh, MD, of the Cole Eye Institute, discusses the results of an analysis of VIEW trial participants he presented at AAO 2019. 

Rishi Singh, MD: Impact of Early Anatomical Dryness on Visual Outcomes

Sumayya Ahmad, MD, assistant professor of ophthalmology at Icahn School of Medicine at Mount Sinai, discusses the results of a study she co-authored examining demographic associations with varying forms of astigmatism

Sumayya Ahmad, MD: Demographic Associations With Astigmatism

Michael Stewart, MD, of Mayo Clinic Jacksonville, discusses the results of 2 phase 2a studies examining the use of AKST4290 in treatment naive and refractory neovascular age-related macular degeneration.

AKST4290, an Oral Therapy for nAMD, Shows Promise in Phase 2a Studies

Aleksandra Rachitskaya, MD, of Cole Eye Institute, discusses a presentation she led at AAO 2019 on novel imaging and surgical techniques. 

Aleksandra Rachitskaya, MD: Novel Imaging and Surgical Techniques

A new study has found that receiving or not receiving topical antibiotics following cataract surgery had no impact on the development of endophthalmitis. 

Topical Antibiotics Not Needed Following Cataract Surgery

A phase 1b study, which was presented by Charles Wykoff, MD, PhD, at AAO 2019, found the novel anti-VEGF therapy KSI-301 shows promise for treating a slew of retinal diseases.

KSI-301 Improves Wet AMD, Diabetic Macular Edema, and Retinal Vein Occlusion

A presentation at AAO 2019 highlighted the ability of the EyeArt screening system to detect diabetic retinopathy with 95.5% sensitivity. 